These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17212928)

  • 21. Function and regulation of collecting duct intercalated cells.
    Schuster VL
    Annu Rev Physiol; 1993; 55():267-88. PubMed ID: 8466177
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaginal Lactobacillus isolates inhibit uropathogenic Escherichia coli.
    Atassi F; Brassart D; Grob P; Graf F; Servin AL
    FEMS Microbiol Lett; 2006 Apr; 257(1):132-8. PubMed ID: 16553843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections.
    Ha US; Cho YH
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S63-7. PubMed ID: 17913471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
    Layton GT; Smithyman AM
    Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.
    Soto SM; Smithson A; Horcajada JP; Martinez JA; Mensa JP; Vila J
    Clin Microbiol Infect; 2006 Oct; 12(10):1034-6. PubMed ID: 16961644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of vaccination in urinary infections caused by Escherichia coli in rats].
    Mathieu D; Jacques L; Auer J; Bizzini B
    Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.
    Bishop BL; Duncan MJ; Song J; Li G; Zaas D; Abraham SN
    Nat Med; 2007 May; 13(5):625-30. PubMed ID: 17417648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the bladder defense mechanism by immunization.
    Uehling DT; Wolf L
    Invest Urol; 1969 Mar; 6(5):520-6. PubMed ID: 4887493
    [No Abstract]   [Full Text] [Related]  

  • 29. Blueprinting the regulatory response of Escherichia coli to the urinary tract.
    Seed PC; Hultgren SJ
    Trends Microbiol; 2005 Jun; 13(6):246-8. PubMed ID: 15936653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevention of recurrent urinary tract infection in women.
    Jameson RM
    Practitioner; 1976 Feb; 216(1292):178-81. PubMed ID: 772658
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.
    Labat F; Pradillon O; Garry L; Peuchmaur M; Fantin B; Denamur E
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):317-21. PubMed ID: 15907455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of subinhibitory concentrations of antibiotics and antibodies on the adherence of Escherichia coli to human uroepithelial cells in vitro.
    Stenqvist K; Sandberg T; Ahlstedt S; Korhonen TK; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():104-7. PubMed ID: 6127798
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.
    Longhi C; Marazzato M; Conte MP; Iebba V; Schippa S; Seganti L; Comanducci A
    J Antibiot (Tokyo); 2009 Feb; 62(2):109-11. PubMed ID: 19198637
    [No Abstract]   [Full Text] [Related]  

  • 34. Prophylaxis against postoperative infection of the urinary tract in patients with cancer of the uterine cervix.
    Magara M; Takase Z; Ishikawa A
    Antimicrob Agents Chemother (Bethesda); 1965; 5():728-33. PubMed ID: 5327530
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modeling of kidney collecting ducts function in the cell culture conditions].
    Gorshkov AN; Komissarchik IaIu
    Tsitologiia; 2011; 53(7):543-54. PubMed ID: 21938926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney intercalated cells are phagocytic and acidify internalized uropathogenic Escherichia coli.
    Saxena V; Gao H; Arregui S; Zollman A; Kamocka MM; Xuei X; McGuire P; Hutchens M; Hato T; Hains DS; Schwaderer AL
    Nat Commun; 2021 Apr; 12(1):2405. PubMed ID: 33893305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intercalated cell function, kidney innate immunity, and urinary tract infections.
    Schwaderer AL; Rajadhyaksha E; Canas J; Saxena V; Hains DS
    Pflugers Arch; 2024 Apr; 476(4):565-578. PubMed ID: 38227050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ounce of prevention.
    Huttner A
    Clin Microbiol Infect; 2018 Oct; 24(10):1037-1038. PubMed ID: 30170134
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary Tract Infections: Renal Intercalated Cells Protect against Pathogens.
    Chelangarimiyandoab F; Mungara P; Batta M; Cordat E
    J Am Soc Nephrol; 2023 Oct; 34(10):1605-1614. PubMed ID: 37401780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial comment to intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
    Damiano R; Cicione A
    Int J Urol; 2012 Dec; 19(12):1112-3. PubMed ID: 23181521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.